Trials / Completed
CompletedNCT07120165
Effectiveness of Myopia Control Interventions : A Comparison of Myopia Control in European Children, Adolescents and Young Adults With Defocus Incorporated Multiple Segments (DIMS) and Highly Aspherical Lenslets (HAL) Spectacles, Atropine, Lenses and Combined Treatments
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 114 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
The prevalence of myopia and its complications has risen considerably in recent decades, particularly among children and teenagers. This trend is also spreading in Europe, driven by the increase in screen time and the intensive use of new technologies and social media, particularly among the younger generation. Several treatment options are available today, including pharmacological treatments with atropine eye drops, as well as optical myopia control systems in the form of glasses or contact lenses. These different treatments have been used in clinical practice at Saint-Étienne University Hospital since 2017 for atropine, and more recently with the development of optical myopia control systems and their combinations. Little clinical data has been published to date on these different treatment combinations in the French population. The investigators would therefore like to set up a database to publish their results and share their experience.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Demographic data collection | Demographic data collection: age, gender, level of education/study, time spent in near vision, sports practice, medical history |
| OTHER | Ophthalmological history | Ophthalmological history: age of myopia discovery, parental refraction, previous refractions, presence of a braking treatment |
| OTHER | Ophthalmological data at each examination | Ophthalmological data at each examination: visual acuity, subjective refraction, cycloplegia with SKIACOL, axial length. |
| OTHER | Potential adverse events | Potential adverse events: halos, photophobia, stinging, infections, etc. |
Timeline
- Start date
- 2024-10-20
- Primary completion
- 2025-05-07
- Completion
- 2025-05-07
- First posted
- 2025-08-13
- Last updated
- 2025-08-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07120165. Inclusion in this directory is not an endorsement.